Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Feb 7:2022:8446294.
doi: 10.1155/2022/8446294. eCollection 2022.

Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging

Affiliations
Randomized Controlled Trial

Clinical Study on the Efficacy of Microwave Ablation (MA) in the Treatment of Stage I Renal Clear Cell Carcinoma by CT and MRI Imaging

Jiang Zhu et al. J Healthc Eng. .

Retraction in

Abstract

We have proposed an effective mechanism to corroborate the efficacy of microwave ablation (MA) in the treatment of stage I renal clear cell carcinoma in this paper. For this purpose, a total of 96 patients with stage I renal clear cell carcinoma presented in our hospital from May 2018 to January 2021 were randomly divided into CT group (n = 48) and MRI group (n = 48). Patients in both groups were treated with microwave ablation after pathological diagnosis. Patients in the CT group received enhanced CT examination to monitor the therapeutic effect; in contrast, patients in the MRI group received MRI examination to monitor their therapeutic effect. The focus areas before and after tumor microwave ablation were compared between the two groups. The patients were followed up to 1 year after the operation, and the microwave ablation inactivation rates of the two groups were compared according to the postoperative follow-up results. There was no significant difference between CT and MRI in the levels of long and short diameter before and after microwave ablation of renal clear cell carcinoma (P > 0.05). In the CT group, CT examination was performed within 24 hours after microwave ablation treatment, and 44 of 48 ablation lesions showed complete ablation. The remaining 4 lesions showed nodular heterogeneous enhancement in the arterial phase, indicating that the tumor remained. Microwave ablation was performed on the residual lesions during the operation, and then enhanced CT was performed again to show that the lesions were ablated completely. In the MRI group, MRI examination was performed within 24 hours after microwave ablation treatment, and 45 of 48 ablation lesions showed complete ablation. The remaining 3 lesions showed nodular heterogeneous enhancement in the arterial phase, indicating that the tumor remained. Microwave ablation was performed on the residual lesions during the operation, and MRI examination showed that the lesions were ablated completely. The patients were followed up to 1 year after the operation, and the microwave ablation inactivation rate of the two groups was compared according to the postoperative follow-up results as the gold standard. The inactivation rate of microwave ablation in the CT group was 89.58 (43/48). The inactivation rate of microwave ablation in the MRI group was 100.00% (48/48). The inactivation rate of microwave ablation in the MRI group was higher than that in the CT group (χ 2 = 5.275, P = 0.021).

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Similar articles

Cited by

References

    1. Akhtar M., Al-Bozom I. A., Al Hussain T. Papillary renal cell carcinoma (PRCC): an update. Advances in Anatomic Pathology . 2019;26(2):124–132. doi: 10.1097/pap.0000000000000220. - DOI - PubMed
    1. Zheng L., Feng H., Yin L., et al. Study on the correlation factors of tumour prognosis after intravascular interventional therapy. Journal of Healthcare Engineering . 2021;2021:1–11. doi: 10.1155/2021/6940056.6940056 - DOI - PMC - PubMed
    1. Ni L., Xue P., An C., et al. Establishment of normal range for thromboelastography in healthy middle-aged and elderly people of weihai in China. Journal of Healthcare Engineering . 2021;2021:1–5. doi: 10.1155/2021/7119779.7119779 - DOI - PMC - PubMed
    1. Wolf M. M., Kimryn Rathmell W., Beckermann K. E. Modeling clear cell renal cell carcinoma and therapeutic implications. Oncogene . 2020;39(17):3413–3426. doi: 10.1038/s41388-020-1234-3. - DOI - PMC - PubMed
    1. Xu W.-H., Xu Y., Wang J., et al. Prognostic value and immune infiltration of novel signatures in clear cell renal cell carcinoma microenvironment. Aging . 2019;11(17):6999–7020. doi: 10.18632/aging.102233. - DOI - PMC - PubMed

Publication types